πŸ‡ΊπŸ‡Έ FDA
Patent

US 9061026

Oligomer-diarylpiperazine conjugates

granted A61KA61K31/495A61K47/60

Quick answer

US patent 9061026 (Oligomer-diarylpiperazine conjugates) held by Nektar Therapeutics expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/495, A61K47/60, A61P, A61P1/04